![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer
Peter Grell, Simona Bořilová, Pavel Fabián, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1901-1901
Open Access | Times Cited: 7
Peter Grell, Simona Bořilová, Pavel Fabián, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1901-1901
Open Access | Times Cited: 7
Showing 7 citing articles:
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
S Mestiri, Ana Sami, Naresh Sah, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access
S Mestiri, Ana Sami, Naresh Sah, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access
HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma
Liang Liu, Zhenshan Zhang, Chenxue Jiang, et al.
Aging (2024)
Open Access | Times Cited: 1
Liang Liu, Zhenshan Zhang, Chenxue Jiang, et al.
Aging (2024)
Open Access | Times Cited: 1
FOXP3: A Player of Immunogenetic Architecture in Lung Cancer
Iwona Ziółkowska‐Suchanek, Magdalena Żurawek
Genes (2024) Vol. 15, Iss. 4, pp. 493-493
Open Access | Times Cited: 1
Iwona Ziółkowska‐Suchanek, Magdalena Żurawek
Genes (2024) Vol. 15, Iss. 4, pp. 493-493
Open Access | Times Cited: 1
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
Mark Baxter, Lindsay C. Spender, David A. Cairns, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103450-103450
Open Access | Times Cited: 1
Mark Baxter, Lindsay C. Spender, David A. Cairns, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103450-103450
Open Access | Times Cited: 1
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis
Yan Qin, Shuai Cheng Li, Lang He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yan Qin, Shuai Cheng Li, Lang He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
Su‐Jin Shin, In Ho Park, Heounjeong Go, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access
Su‐Jin Shin, In Ho Park, Heounjeong Go, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access